Innophos Holdings Inc. (IPHS) Stake Cut by BNP Paribas Arbitrage SA
BNP Paribas Arbitrage SA decreased its stake in Innophos Holdings Inc. (NASDAQ:IPHS) by 47.9% during the third quarter, Holdings Channel reports. The fund owned 3,357 shares of the company’s stock after selling 3,091 shares during the period. BNP Paribas Arbitrage SA’s holdings in Innophos Holdings were worth $131,000 at the end of the most recent quarter.
Other hedge funds also recently bought and sold shares of the company. Mason Street Advisors LLC bought a new stake in Innophos Holdings during the second quarter valued at about $160,000. Public Employees Retirement System of Ohio increased its position in shares of Innophos Holdings by 13.2% in the second quarter. Public Employees Retirement System of Ohio now owns 3,132 shares of the company’s stock worth $132,000 after buying an additional 366 shares in the last quarter. Personal Capital Advisors Corp increased its position in shares of Innophos Holdings by 27.0% in the second quarter. Personal Capital Advisors Corp now owns 80,913 shares of the company’s stock worth $3,415,000 after buying an additional 17,199 shares in the last quarter. Schwab Charles Investment Management Inc. increased its position in shares of Innophos Holdings by 7.2% in the second quarter. Schwab Charles Investment Management Inc. now owns 131,427 shares of the company’s stock worth $5,548,000 after buying an additional 8,772 shares in the last quarter. Finally, Arizona State Retirement System increased its position in shares of Innophos Holdings by 2.0% in the second quarter. Arizona State Retirement System now owns 10,073 shares of the company’s stock worth $425,000 after buying an additional 200 shares in the last quarter. Hedge funds and other institutional investors own 93.31% of the company’s stock.
Innophos Holdings Inc. (NASDAQ:IPHS) opened at 39.71 on Thursday. The stock has a 50 day moving average price of $39.58 and a 200-day moving average price of $39.04. The firm has a market cap of $764.06 million, a P/E ratio of 30.45 and a beta of 0.81. Innophos Holdings Inc. has a one year low of $22.06 and a one year high of $44.42.
Innophos Holdings (NASDAQ:IPHS) last announced its earnings results on Tuesday, August 2nd. The company reported $0.63 EPS for the quarter, topping the consensus estimate of $0.57 by $0.06. The company had revenue of $181.90 million for the quarter, compared to analysts’ expectations of $199.70 million. Innophos Holdings had a return on equity of 9.83% and a net margin of 3.47%. The business’s revenue for the quarter was down 16.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.65 earnings per share. Analysts predict that Innophos Holdings Inc. will post $2.44 EPS for the current fiscal year.
Separately, Zacks Investment Research downgraded Innophos Holdings from a “strong-buy” rating to a “hold” rating in a report on Wednesday, July 6th.
In other Innophos Holdings news, Director Robert J. Zatta bought 1,000 shares of the firm’s stock in a transaction dated Friday, September 9th. The shares were bought at an average price of $40.31 per share, for a total transaction of $40,310.00. Following the completion of the acquisition, the director now owns 6,351 shares of the company’s stock, valued at $256,008.81. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 2.00% of the company’s stock.
Innophos Holdings Company Profile
Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. Its segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and GTSP & Other.
Want to see what other hedge funds are holding IPHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innophos Holdings Inc. (NASDAQ:IPHS).
Receive News & Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.